User profiles for Saskia Lawson-Tovey
Saskia Lawson-ToveyCentre for Musculoskeletal Research, University of Manchester Verified email at manchester.ac.uk Cited by 2759 |
Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician …
…, L Jacobsohn, P Katz, S Lawson-Tovey… - Annals of the …, 2020 - ard.bmj.com
Objectives COVID-19 outcomes in people with rheumatic diseases remain poorly understood.
The aim was to examine demographic and clinical factors associated with COVID-19 …
The aim was to examine demographic and clinical factors associated with COVID-19 …
Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported …
…, MA Gianfrancesco, S Lawson-Tovey… - Annals of the …, 2021 - ard.bmj.com
Objectives To determine factors associated with COVID-19-related death in people with
rheumatic diseases. Methods Physician-reported registry of adults with rheumatic disease and …
rheumatic diseases. Methods Physician-reported registry of adults with rheumatic disease and …
Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician …
PM Machado, S Lawson-Tovey, A Strangfeld… - Annals of the …, 2022 - ard.bmj.com
Objectives To describe the safety of vaccines against SARS-CoV-2 in people with
inflammatory/autoimmune rheumatic and musculoskeletal disease (I-RMD). Methods Physician-…
inflammatory/autoimmune rheumatic and musculoskeletal disease (I-RMD). Methods Physician-…
[HTML][HTML] Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: results from the COVID-19 Global …
…, L Carmona, EF Mateus, S Lawson-Tovey… - Annals of the …, 2021 - ard.bmj.com
Objective To investigate baseline use of biologic or targeted synthetic (b/ts) disease-modifying
antirheumatic drugs (DMARDs) and COVID-19 outcomes in rheumatoid arthritis (RA). …
antirheumatic drugs (DMARDs) and COVID-19 outcomes in rheumatoid arthritis (RA). …
Association between tumor necrosis factor inhibitors and the risk of hospitalization or death among patients with immune-mediated inflammatory disease and COVID …
…, L Carmona, EF Mateus, S Lawson-Tovey… - JAMA network …, 2021 - jamanetwork.com
Importance Although tumor necrosis factor (TNF) inhibitors are widely prescribed globally
because of their ability to ameliorate shared immune pathways across immune-mediated …
because of their ability to ameliorate shared immune pathways across immune-mediated …
Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology Alliance
…, KL Hyrich, L Carmona, S Lawson-Tovey… - Annals of the …, 2022 - ard.bmj.com
Aim To determine characteristics associated with more severe outcomes in a global registry
of people with systemic lupus erythematosus (SLE) and COVID-19. Methods People with …
of people with systemic lupus erythematosus (SLE) and COVID-19. Methods People with …
Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a …
…, L Gossec, L Carmona, S Lawson-Tovey… - The Lancet …, 2021 - thelancet.com
Background Patients with primary systemic vasculitis or polymyalgia rheumatica might be at
a high risk for poor COVID-19 outcomes due to the treatments used, the potential organ …
a high risk for poor COVID-19 outcomes due to the treatments used, the potential organ …
SARS-CoV-2 breakthrough infections among vaccinated individuals with rheumatic disease: results from the COVID-19 Global Rheumatology Alliance provider …
…, C Harrison, Z Izadi, S Rush, S Lawson-Tovey… - RMD open, 2022 - rmdopen.bmj.com
Objective While COVID-19 vaccination prevents severe infections, poor immunogenicity in
immunocompromised people threatens vaccine effectiveness. We analysed the clinical …
immunocompromised people threatens vaccine effectiveness. We analysed the clinical …
Response to:'Correspondence on 'Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global …
…, M Gianfrancesco, S Lawson-Tovey… - Annals of the …, 2023 - ard.bmj.com
We thank Ben Mulhearn 1 for his correspondence on our article. 2 The correspondence
raises the important question of whether moderate-dose to high-dose glucocorticoid (GC) …
raises the important question of whether moderate-dose to high-dose glucocorticoid (GC) …
SARS-CoV-2 infection after vaccination in patients with inflammatory rheumatic and musculoskeletal diseases
S Lawson-Tovey, KL Hyrich, L Gossec… - Annals of the …, 2022 - ard.bmj.com
This content has been supplied by the author (s). It has not been vetted by BMJ Publishing
Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or …
Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or …